From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: TW

Search articles by EPIC code

More GlaxoSmithKline and Unilever excitement awaits…and then onto Taylor Wimpey

Of course I am excited to see GlaxoSmithKline (GSK) shares up nicely today. No surprise, akin to my comments here yesterday, that it has formally told Unilever (ULVR) where to go. Suffice to say there is going to a load of full year number updates from the two names on 9th February (GSK) and 10th February (Unilever), but today’s additional announcement by the former of ‘detailed financial information and future growth ambitions for the new Consumer Healthcare business at a virtual Capital Markets Day for investors and analysts on Monday 28th February 2022’, is really going to be worth a listen to. As noted in my update yesterday I am holding onto my GSK shares. Let’s talk about something else and I see Taylor Wimpey (TW.) is out with its ‘trading statement for the year ended 31 December 2021’ today.


Normal Business During Lockdown Helps this Canny Builder to Construct a Higher Share Price

Hello, Share Seekers. There’s no wonder that home builders are doing well even in lockdown periods. It’s still permitted that potential buyers can walk around show homes and buy if they want to. Also, building work is going ahead as normal. While estate agents report that house prices are not only maintained but in some areas rising fast. Take Taylor Wimpey (TW.) for instance...

Page 2 of 5 (44 articles)
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments